BridgeBio Pharma, Inc. 10-Q filing
Filed 2025-10-29 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001743881-25-000012
- Form type
- 10-Q
- CIK
- 0001743881
- Primary document
- https://www.sec.gov/Archives/edgar/data/1743881/000174388125000012/bbio-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BridgeBio Pharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $347.9M | - | - |
| Cost Of Revenue | $12.9M | - | - |
| Operating Income | $-383.8M | - | - |
| Eps Basic | -2.79 | - | - |
| Eps Diluted | -2.79 | - | - |
| Cash And Equivalents | $643.0M | - | - |
| Total Assets | $998.3M | - | - |
| Total Liabilities | $2.9B | - | - |
| Shareholders Equity | $-1.9B | - | - |
| Operating Cash Flow | $-389.5M | - | - |
| Capital Expenditures | $1.1M | - | - |